Dr. Anne H. Cross, MD

Dr. Cross practices at Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health.

Dr. Cross' NPI, 1073531596, was assigned on July 17, 2006. Dr. Cross graduated from Heersink School of Medicine - Birmingham in 1980. Dr. Cross holds Missouri license R6P87.

Dr. Cross' primary practice is Barnes-Jewish Hospital, at One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110 in St. Louis City. The practice phone is (314) 747-3000. Dr. Cross also practices at Barnes-Jewish Hospital, 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110.

Dr. Cross' primary practice is Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health. Dr. Cross is also affiliated with Missouri Baptist Medical Center. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Cross to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cross practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Cross' primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Cross is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Cross' licenses on file in 2 states: Missouri and Illinois.

Dmand AI lists multiple sclerosis among the conditions Dr. Cross treats.

CMS data shows 169 Medicare services from Dr. Cross across 3 procedure codes in 2024, for 66 Medicare patients. Medicare paid $9,151 for them. Every service was in an office.

CMS counts 66 Medicare patients who saw Dr. Cross in 2024. The largest group is 65 to 74, with 27 patients. 62% of them have high cholesterol, and 58% have high blood pressure. 20% are also on Medicaid. Their average risk score is 2.13, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cross' median patient age at 59, with 74% women.

In 2024, Dr. Cross wrote 795 Medicare Part D claims for 94 patients. 83% of them were for generic drugs. CMS names the drug for 568 of them, across 22 drugs with 11 or more claims each, at $1,024,978 in total drug cost. In 2023, CMS named 856 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Cross for performance year 2024, reported as part of a group. Dr. Cross accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cross as offering telehealth.

Dmand AI links 310 papers to Dr. Cross, published from 2005 to 2025. 2017 was the busiest year, with 13. The most frequent topics are Multiple Sclerosis, Encephalomyelitis, Autoimmune, Experimental and Magnetic Resonance Imaging. Dr. Cross has published most often in Neurology. Dr. Cross' most frequent co-authors are Gregory F. Wu, MD, Matthew Ryan Brier, MD and Salim Chahin, MD.

Dmand AI links Dr. Cross to 4 clinical trials. Conditions studied include Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting and Demyelinating Autoimmune Diseases, CNS. Washington University School of Medicine sponsors the most, 2.

CMS Open Payments shows 316 general payments to Dr. Cross from 21 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 64% of the total. Genentech, Inc. paid the most, $83,844. It also lists 41 research payments totaling $33,235 from 2017 to 2025.

Dmand AI lists 17 awards for Dr. Cross, most recently Faculty Achievement Award in 2014. Dr. Cross serves on International Progressive MS Alliance.

Dr. Cross graduated from Heersink School of Medicine - Birmingham in 1980. Dr. Cross is a member of AOA, AAN, American Neurological Association, America's Committee for Treatment and Research on MS and Consortium of MS Centers.

Dr. Cross is in network with 17 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.